早期阶段试验和现实世界的证据在药物开发中的作用
Harriette G C Van Spall1,2, Arnaud Bastien3, Bernard Gersh4
1Department of Medicine, Department of Health Research Methods, Evidence, and Impact; Research Institute of St. Joseph's, McMaster University, Hamilton, Ontario, Canada.
在第三阶段随机对照试验 (RCT) 之外探索各种证据来源可以加速心血管药物开发. 整合现实数据和实用试验可以提高概括性和效率.
科学领域:
- 心血管医学 心血管医学
- 临床试验方法论 临床试验方法论
- 药物开发 药物开发
背景情况:
- 第三期随机对照试验 (RCT) 是至关重要的,但在可行性,成本,持续时间和通用性方面存在局限性.
- 替代证据来源对于推动药物开发至关重要,特别是在心血管医学中.
研究的目的:
- 讨论可以补充传统第三阶段RCT的补充证据来源.
- 探索加速开发新型心血管药物的战略.
主要方法:
- 该观点综合了第19届全球心血管临床试验家会议的见解.
- 讨论涉及多种利益相关者,包括试验者,患者,临床医生,监管机构,资助者和行业代表.
主要成果:
- 基础科学,早期试验,来自注册表/观测数据的真实世界证据 (RWE) 和实用试验提供了有价值的补充数据.
- 这些替代来源可以提供临床益处的证据,解决罕见疾病试验中的挑战,并在现实环境中评估治疗效果.
结论:
- 将不同证据流与第三阶段RCT相结合,可以提高心血管药物开发的效率和适用性.
- 对证据生成的多方面的方法是加速向患者提供新型心血管治疗的关键.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
相关概念视频
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Discovery: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
